GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Degree of Financial Leverage

Halberd (Halberd) Degree of Financial Leverage : 0.92 (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Degree of Financial Leverage?

Degree of Financial Leverage (DFL) measures the percentage change in EPS for a unit change in Earnings Before Interest and Taxes (EBIT). Halberd's Degree of Financial Leverage for the quarter that ended in Jul. 2023 was 0.92. The higher Degree of Financial Leverage, the more volatile earnings will be.

The industry rank for Halberd's Degree of Financial Leverage or its related term are showing as below:

HALB's Degree of Financial Leverage is ranked better than
53.44% of 1497 companies
in the Biotechnology industry
Industry Median: 0.96 vs HALB: 0.92

Halberd Degree of Financial Leverage Historical Data

The historical data trend for Halberd's Degree of Financial Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Degree of Financial Leverage Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Degree of Financial Leverage
- - 0.92

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Degree of Financial Leverage - - 0.92

Competitive Comparison of Halberd's Degree of Financial Leverage

For the Biotechnology subindustry, Halberd's Degree of Financial Leverage, along with its competitors' market caps and Degree of Financial Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Halberd's Degree of Financial Leverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's Degree of Financial Leverage distribution charts can be found below:

* The bar in red indicates where Halberd's Degree of Financial Leverage falls into.



Halberd Degree of Financial Leverage Calculation

Halberd's Degree of Financial Leverage for the quarter that ended in Jul. 2023 is calculated as:

Degree of Financial Leverage=% Change in Earnings per Share (Diluted)**/% Change in EBIT
=( -0.001 (Jul. 2023) / -0.003 (Jul. 2022) - 1 )/( -0.447 (Jul. 2023) / -1.619 (Jul. 2022) - 1 )
=-0.6667/-0.7239
=0.92***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EPS and EBIT was used to calculate Degree of Financial Leverage.
*** Please be aware that the Degree of Financial Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Halberd  (OTCPK:HALB) Degree of Financial Leverage Explanation

Degree of Financial Leverage (DFL) is a leverage ratio that measures the sensitivity of a company’s Earnings per Share (EPS) to fluctuations in its operating income, also referred to as Earnings Before Interest and Taxes (EBIT), resulting from adjustments in its capital structure. DFL is an essential tool for companies to assess the appropriate level of debt or financial leverage in their capital structure. When EBIT remains relatively stable, it results in stable earnings and earnings per share. In such cases, the company may consider taking on substantial debt. However, for companies operating in industries with significant fluctuations in EBIT, it is advisable to keep debt at a manageable level.

The higher Degree of Financial Leverage, the more volatile earnings will be. Because interest is a fixed expense, leverage can amplify earnings and EPS. This is beneficial when EBIT is growing, but it can become problematic in tough economic conditions when EBIT is under pressure.

Be Aware

The use of financial leverage varies across different industries and business sectors, and the application of Degree of Financial Leverage (DFL) should be adjusted accordingly.


Halberd Degree of Financial Leverage Related Terms

Thank you for viewing the detailed overview of Halberd's Degree of Financial Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Industry
Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236